Compare WAY & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WAY | SHC |
|---|---|---|
| Founded | 1999 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.4B |
| IPO Year | 2023 | 2020 |
| Metric | WAY | SHC |
|---|---|---|
| Price | $19.83 | $15.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 7 |
| Target Price | ★ $36.59 | $20.33 |
| AVG Volume (30 Days) | 2.6M | ★ 3.9M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 569.23 | 68.75 |
| EPS | ★ 0.22 | 0.09 |
| Revenue | $1,099,278,000.00 | ★ $1,163,617,000.00 |
| Revenue This Year | $18.26 | $7.51 |
| Revenue Next Year | $10.62 | $6.00 |
| P/E Ratio | ★ $88.05 | $175.06 |
| Revenue Growth | ★ 16.50 | 5.74 |
| 52 Week Low | $18.02 | $10.80 |
| 52 Week High | $41.30 | $19.85 |
| Indicator | WAY | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 44.69 | 52.95 |
| Support Level | $18.02 | $15.16 |
| Resistance Level | $20.39 | $16.48 |
| Average True Range (ATR) | 0.84 | 0.43 |
| MACD | 0.18 | 0.01 |
| Stochastic Oscillator | 55.62 | 60.87 |
Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. Its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.